MONCYTE Health will take part in the European Society of Cardiology (ESC) Congress 2025 in Madrid, showcasing new insights into the role of cellular lipid metabolism in cardiovascular disease.
Our presentation will highlight how alterations in cellular lipid metabolism are linked to outcomes of statin treatment and residual cardiovascular risk—an important step toward truly personalized cardiovascular care.
Presentation details
🗓 Date: August 30, 2025
🕝 Time: 13:15–14:00
📍 Location: Station 11 – Research Gateway, IFEMA Madrid
🔈 Speaker: Dr. Simon Pfisterer, CSO & Founder, MONCYTE Health
If you are working in lipid metabolism, dyslipidaemia, or cardiovascular disease prevention, we invite you to join us at ESC 2025 and explore new approaches to advancing precision medicine in atherosclerosis and cardiovascular care.